welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
withdrawn
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
study id #: NCT00026468
condition: Colorectal Cancer, Small Intestine Cancer
status: withdrawn
purpose:RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
intervention: Drug: exisulind
study details
study contacts
expertly curated content related to this topic
-
Laparoscopic Total Colectomy and Proctocolectomy for the Treatment of Familial Adenomatous PolyposisOBJECTIVE : To evaluate the safety, feas...
-
Nonsteroidal Anti-Inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesNumerous experimental, epidemiologic, an...
-
A Total Laparoscopic Approach Reduces the Infertility Rate after Ileal Pouch-Anal Anastomosis: A 2-Center StudyOBJECTIVE: To assess the infertility ra...
-
A Proposed Staging System and Stage-Specific Interventions for Familial Adenomatous PolyposisBACKGROUND : It is not possible to accur...
-
Dual Focus NBI and pCLE in FAP Related Duodenal AdenomaBackground: Familial adenomatous pol...
-
Chemoprevention in Lynch SyndromeCAPP1 tested aspirin 600 mg/day and/or r...
-
Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposi...Abstract To identify gene expression bi...